Skip to main content

Animations

MJFF Publications

7141 - 7150 of 8761 Results
Title
Year
  • Year
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • Summary Details
    OPEN
    Title: Genetic identification of cell types underlying brain complex traits yields insights into the etiology of Parkinson’s disease
    Journal Name: Nature Genetics
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41588-020-0610-9
    Citation Count: 295
  • Summary Details
    OPEN
    Title: Shared proteomic effects of cerebral atherosclerosis and Alzheimer’s disease on the human brain
    Journal Name: Nature Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41593-020-0635-5
    Citation Count: 136
  • Summary Details
    OPEN
    Title: Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41591-020-0755-1
    Citation Count: 959
  • Summary Details
    RESTRICTED
    Title: Monoamine oxidase A inhibition with moclobemide enhances the anti-parkinsonian effect of L-DOPA in the MPTP-lesioned marmoset
    Journal Name: Naunyn-Schmiedeberg's Archives of Pharmacology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s00210-020-01933-y
    Citation Count: 2
  • Summary Details
    RESTRICTED
    Title: Monoamine oxidase A inhibition as monotherapy reverses parkinsonism in the MPTP-lesioned marmoset
    Journal Name: Naunyn-Schmiedeberg's Archives of Pharmacology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s00210-020-01927-w
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Disease modifying treatment trials in Parkinson’s disease: how to balance expectations and interests of patients, physicians and industry partners?
    Journal Name: Neurological Research and Practice
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s42466-020-00076-y
    Citation Count: 3
  • Summary Details
    OPEN
    Title: A machine learning-based classification approach on Parkinson’s disease diffusion tensor imaging datasets
    Journal Name: Neurological Research and Practice
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s42466-020-00092-y
    Citation Count: 29
  • Summary Details
    RESTRICTED
    Title: Enhancing convolution-based sentiment extractor via dubbed N-gram embedding-related drug vocabulary
    Journal Name: Network Modeling Analysis in Health Informatics and Bioinformatics
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s13721-020-00248-5
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Globus Pallidus Internus (GPi) Deep Brain Stimulation for Parkinson’s Disease: Expert Review and Commentary
    Journal Name: Neurology and Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1007/s40120-020-00220-5
    Citation Count: 52
  • Summary Details
    RESTRICTED
    Title: Levodopa-carbidopa intestinal gel is an option in Parkinson’s disease with hyponatremia induced by dopamine agonists
    Journal Name: Neurological Sciences
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s10072-020-04501-7
    Citation Count: 3
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.